HGHCX
Price
$26.03
Change
-$0.06 (-0.23%)
Updated
Nov 19 closing price
Net Assets
833.98M
JFNIX
Price
$81.94
Change
-$0.17 (-0.21%)
Updated
Nov 19 closing price
Net Assets
4.95B
Interact to see
Advertisement

HGHCX vs JFNIX

Header iconHGHCX vs JFNIX Comparison
Open Charts HGHCX vs JFNIXBanner chart's image
Hartford Healthcare C
Price$26.03
Change-$0.06 (-0.23%)
VolumeN/A
Net Assets833.98M
Janus Henderson Global Life Sciences I
Price$81.94
Change-$0.17 (-0.21%)
VolumeN/A
Net Assets4.95B
HGHCX vs JFNIX Comparison Chart in %
View a ticker or compare two or three
VS
HGHCX vs. JFNIX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHCX is a Hold and JFNIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.95B vs. HGHCX (834M). JFNIX pays higher dividends than HGHCX: JFNIX (0.35) vs HGHCX (0.00). HGHCX was incepted earlier than JFNIX: HGHCX (26 years) vs JFNIX (16 years). HGHCX (2.07) is less costly to investors than JFNIX (0.77). HGHCX is a more actively managed with annual turnover of: 40.00 vs. JFNIX (35.00). HGHCX has a lower initial minimum investment than JFNIX: HGHCX (2000) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : 10.62 vs. HGHCX (1.05). JFNIX return over 5 years is better than : 17.36 vs. HGHCX (-23.20).
HGHCXJFNIXHGHCX / JFNIX
Total Expense Ratio2.070.77269%
Annual Report Gross Expense Ratio2.070.77269%
Fund Existence26 years16 years-
Gain YTD11.25820.46555%
Front LoadN/AN/A-
Min. Initial Investment2000250080%
Min. Initial Investment IRAN/AN/A-
Net Assets834M4.95B17%
Annual Yield % from dividends0.000.35-
Returns for 1 year1.0510.6210%
Returns for 3 years5.9326.8022%
Returns for 5 years-23.2017.36-134%
Returns for 10 years-24.8852.25-48%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VAFFX34.850.30
+0.87%
Invesco American Franchise R6
GLNAX23.350.05
+0.21%
MFS Global New Discovery A
QCBGX22.680.01
+0.04%
Federated Hermes MDT Balanced C
ADECX18.37N/A
N/A
Columbia Intrinsic Value C
MGWRX60.19N/A
N/A
MFS Global Growth R2